发明名称 CONTROLLED RELEASED CARVEDIOLOL FORMULATION
摘要 A CONTROLLED RELEASE CARVEDILOL FORMULATION FOR LESS FREQUENT, PREFERABLY ONCE DAILY ADMINISTRATION IS DESCRIBED. THE CONTROLLED RELEASE FORMULATION COMPRISES A THERAPEUTICALLY EFFECTIVE AMOUNT OF CARVEDILOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A MATRIX FORMING POLYMER, A SOLUBILITY ENHANCER AND A PHARMACEUTICALLY ACCEPTABLE CARRIER. IN ONE EMBODIMENT, A CONTROLLED RELEASE FORMULATION HAVING A THERAPEUTICALLY EFFECTIVE AMOUNT OF CARVEDILOL IS CONTAINED IN TWO OR MORE SUBUNITS HAVING DIFFERENT RELEASE PROFILES. THE CONTROLLED RELEASE FORMULATION IS USABLE IN THE TREATMENT AND/OR PROPHYLAXIS OF ONE OR MORE CONDITIONS SUCH AS CARDIOVASCULAR DISORDERS.
申请公布号 MY157299(A) 申请公布日期 2016.05.31
申请号 MY2012PI01433 申请日期 2010.09.29
申请人 TSH BIOPHARM CORPORATION LTD.;INNOPHARMAX, INC. 发明人 HAO, WEI-HUA;LIN, TSUNG-HSIN;LV, TA-CHIEN
分类号 A61K9/20 主分类号 A61K9/20
代理机构 代理人
主权项
地址